Courtney V. Fletcher
Affiliations: | 1983-2002 | Experimental and Clinical Pharmacology | University of Minnesota, Twin Cities, Minneapolis, MN |
2002-2007 | Clinical Pharmacy | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO | |
2007- | Pharmacy | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
antiviral agentsWebsite:
https://www.unmc.edu/aboutus/leadership/dean-directors/cop-dean.htmlGoogle:
"Courtney V. Fletcher"Bio:
http://www.washington.edu/provost/files/2014/04/Fletcher_Courtney_cv.pdf
Mean distance: (not calculated yet)
Children
Sign in to add traineeGautam Baheti | grad student | 2012 | University of Nebraska Medical Center |
Edward P. Acosta | post-doc | 1992-1994 | UMN |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Harwood OE, Matschke LM, Moriarty RV, et al. (2023) CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection. Plos Pathogens. 19: e1011676 |
Harwood OE, Matschke LM, Moriarty RV, et al. (2023) CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques. Biorxiv : the Preprint Server For Biology |
Fletcher CV, Kroon E, Schacker T, et al. (2022) Persistent HIV transcription and Variable ARV penetration in lymph nodes during plasma viral suppression. Aids (London, England) |
Miller JS, Davis ZB, Helgeson E, et al. (2022) Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial. Nature Medicine |
Podany AT, Pham M, Sizemore E, et al. (2021) Efavirenz pharmacokinetics and HIV-1 viral suppression among patients receiving TB treatment containing daily high-dose rifapentine. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Kendall MA, Lalloo U, Fletcher CV, et al. (2021) Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 73: 706-715 |
Dyavar SR, Kumar S, Gautam N, et al. (2021) Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c mice. The Journal of Antimicrobial Chemotherapy |
Hoque TMD, Cattin A, Whyte-Allman SK, et al. (2021) Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals. Journal of Acquired Immune Deficiency Syndromes (1999). 87: 1093-1101 |
Fletcher CV, Dyavar SR, Acharya A, et al. (2021) The Contributions of Clinical Pharmacology to HIV Cure Research. Clinical Pharmacology and Therapeutics |
Kendall MA, Lalloo U, Fletcher CV, et al. (2021) Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin vs. Lopinavir/Ritonavir + Daily Rifabutin for Treatment of HIV-TB Coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |